posted on Sep, 28 2005 @ 10:38 AM
Some reasons drug companies don't release negative study findings:
1. They don't want competition realising their potential errors, and thus improving on the product before they get chance themselves.
2. In the clinical trial phases prior to submission/approval, it's hard to actually discern much of the time whether adverse events are actually
caused by the drug or not; it doesn't make sense to scare the public if there's no proven link.
3. If efficacy is in question, the drug would not be approved anyway, and thus would never reach the public.
The trouble with anti-depressants and suicide is simple:
There's just no way to tell whether a particular patient's depression would or would not have included suicidal ideology to begin with. This
particular research group is already much higher risk for suicide. In addition, clinical trials invariably end up with deaths amongst their numbered
patients; the difficulty once again is assessing causality.
This is less to do with an FDA conspiracy than it is to do with fair business practices...if the FDA were allowed to release every bit of clinical
data, you'd find panic-mongering going through the roof and that would feasibly result in even more deaths as people would be too afraid to take the
drugs that often save their lives, and this would in turn cripple an industry which does, regardless of the "conspiracy" factor, end up saving more
lives than it harms.
Bear in mind:
If you see "headache" listed as a possible side-effect, this does not mean you're going to get a headache. Same with palpitations, rash and/or
That's just not how side-effect reporting works